Form 4: USANA Health Sciences: Officer Joshua Foukas Reports Stock Transactions

Chief Legal Officer Joshua Foukas reports transactions involving USANA Health Sciences stock, including the exercise of restricted stock units and subsequent disposal of shares to cover tax obligations.

Summary

• On February 8, 2025, Joshua Foukas, Chief Legal Officer of USANA Health Sciences, executed transactions involving the company's common stock.
• These transactions included the vesting and exercise of 1,667 and 3,596 restricted stock units, which convert into an equal number of common shares.
• Following the exercise of these units, Mr. Foukas disposed of 706 and 1,523 shares of common stock at a price of $30.65 to satisfy tax obligations.
• After these transactions, Mr. Foukas directly owns 5,732 shares of common stock and 18,581 restricted stock units.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document simply reports stock transactions by an officer, which is a routine occurrence. There is no indication of positive or negative implications for the company's performance.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock. It's a standard practice for officers to exercise stock options or restricted stock units and then sell a portion of the shares to cover the associated tax liabilities.

Comparison to Industry Standards

• Form 4 filings are standard practice across publicly traded companies, including USANA's competitors in the health and wellness industry such as Herbalife Nutrition and Nu Skin Enterprises.
• The reported transactions are typical for executives receiving stock-based compensation, with sales often timed to cover tax obligations upon vesting.
• The volume of shares traded is relatively small compared to the overall market capitalization of USANA, suggesting a limited impact on the stock price.

Stakeholder Impact

• The transactions are unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors, as they represent a small portion of the overall outstanding shares.

Key Dates

Keywords

USANA Health Sciences, Joshua Foukas, stock transactions, restricted stock units, Form 4, insider trading, USNA